CyberKnife for hilar lung tumors: report of clinical response and toxicity
<p>Abstract</p> <p>Objective</p> <p>To report clinical efficacy and toxicity of fractionated CyberKnife radiosurgery for the treatment of hilar lung tumors.</p> <p>Methods</p> <p>Patients presenting with primary and metastatic hilar lung tumors,...
Main Authors: | Collins Sean P, William Harter K, Subramaniam Deepa, Vahdat Saloomeh, Yu Xia, Suy Simeng, Oermann Eric, Ju Andrew, Unger Keith, Dritschilo Anatoly, Anderson Eric, Collins Brian T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/3/1/39 |
Similar Items
-
CyberKnife with tumor tracking: An effective alternative to wedge resection for high-risk surgical patients with stage I non-small cell lung cancer (NSCLC)
by: Sean eCollins, et al.
Published: (2012-02-01) -
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment
by: Chang Thomas, et al.
Published: (2010-02-01) -
Common Error Pathways in CyberKnife™ Radiation Therapy
by: Brandon T. Mullins, et al.
Published: (2020-07-01) -
CyberKnife Boost in Pediatric Ependymoma of the Fourth Ventricle
by: Amr Mousa, et al.
Published: (2020-06-01) -
Comparative analysis of plan quality and delivery efficiency: ZAP-X vs. CyberKnife for brain metastases treatment
by: Ying Niu, et al.
Published: (2024-06-01)